Related Experiment Video
Updated: Jun 14, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
HMGB1, a potent proinflammatory cytokine in sepsis
Wenchang Huang1, Yaoqing Tang, Lei Li
1Department of Surgery Intensive Care Unit, Affiliated Ruijin Hospital of Medical College of Shanghai Jiaotong University, Shanghai 200025, China.
Abstract:
High-mobility group box 1 (HMGB1), a highly conserved protein previously known as a DNA-binding protein involved in maintenance of nucleosome structure and regulation of gene transcription, was recently found to act as a potent proinflammatory cytokine during infection responses. Levels of HMGB1 increase in serum and tissues during infection, especially in sepsis. Sepsis, which is a systemic inflammatory response disease, is the most severe complication of infection and is a deadly disease, and HMGB1 acting as a potent proinflammatory cytokine involve in the delayed endotoxin lethality and systemic inflammatory response. A growing number of studies have demonstrated HMGB1 is a cytokine that can mediate inflammation and is a potential therapeutic target in experimental models of sepsis. To reduce sepsis-related mortality, a better understanding of HMGB1 is essential. In this article, we will describe the structure, release process, intracellular function, and cell surface receptors of HMGB1, but will primarily focus on its extracellular roles and mechanism in inflammation, especially in sepsis.
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Bacterial Meningitis II: Pathophysiology
Gastritis II: Pathophysiology
Differentiation of Common Myeloid Progenitor Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
